Health Secretary Robert F. Kennedy Jr. announced a new federal pilot program on May 29 aimed at reducing Lyme disease cases by 25%. The initiative includes increased funding for research and improved diagnostics, targeting a disease that affects roughly 476,000 Americans annually. Kennedy emphasized the need to address chronic symptoms, stating, 'Millions of Americans living with Lyme disease and other tick-borne illnesses have struggled for decades to get diagnoses, treatments, and care.'
The Department of Health and Human Services (HHS) outlined additional measures, including new research funding from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). These efforts aim to enhance early detection and treatment, as well as support for patients with post-treatment Lyme disease syndrome (PTLDS), a condition affecting an estimated 2 million Americans. Kennedy stressed that addressing chronic Lyme symptoms is a 'top HHS priority,' adding, 'We are listening to patients, following the science, and taking action.'
Lyme Disease Advocates and Healthcare Professionals
Lyme disease advocates have long criticized the healthcare system for dismissing patients with lingering symptoms. Physicians and patients report a range of debilitating conditions, including cardiovascular issues and autoimmune disorders. Dr. Stephanie Haridopolos, director of communications for the Office of the Surgeon General, affirmed the administration's commitment to developing better testing and treatment, stating, 'We see you, we hear you. We’re going to make the invisible diseases visible now through Secretary Kennedy’s leadership.'
Policy and Research Priorities
The new initiatives focus on prevention, diagnostics, and treatment of Lyme disease and other tick-borne illnesses. The CDC and NIH will allocate additional resources to research, while HHS will expand public awareness campaigns. Kennedy’s announcement comes amid growing concerns over the rising prevalence of Lyme disease, particularly in regions like New Hampshire, where tick populations are expanding.
Patient and Medical Community Response
Patients and healthcare providers have welcomed the new measures, though some express skepticism about the feasibility of reducing cases by 25%. Advocates highlight the need for long-term funding and policy changes to ensure sustained progress. Meanwhile, researchers emphasize the importance of early intervention, as patients treated promptly with antibiotics typically recover quickly, while 10-20% of treated patients may still experience persistent symptoms.